Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Head and neck cancer

Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy

Date

23 Nov 2019

Session

Mini Oral session - Head and neck cancer

Topics

Tumour Site

Head and Neck Cancers

Presenters

Jingjing Miao

Citation

Annals of Oncology (2019) 30 (suppl_9): ix97-ix106. 10.1093/annonc/mdz428

Authors

J. Miao1, M. Di1, Y. Cao2, L. Wang1, W. Xiao3, M. Zhu1, B. Chen1, S. Huang3, F. Han3, X. Deng3, Y. Xiang1, M.L.K. Chua4, X. Guo1, C. Zhao1

Author affiliations

  • 1 Department Of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 510060 - Guangzhou/CN
  • 2 Department Of Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, 510060 - Guangzhou/CN
  • 3 Department Of Radiation Oncology, Sun Yat-sen University Cancer Center, 510060 - Guangzhou/CN
  • 4 Division Of Radiation Oncology, National Cancer Center Singapore, 169610 - Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.